Results 11 to 20 of about 30,551,261 (265)

HIV-1 Latency in Monocytes/Macrophages [PDF]

open access: yesViruses, 2014
Human immunodeficiency virus type 1 (HIV-1) targets CD4+ T cells and cells of the monocyte/macrophage lineage. HIV pathogenesis is characterized by the depletion of T lymphocytes and by the presence of a population of cells in which latency has been ...
Amit Kumar, Wasim Abbas, Georges Herbein
doaj   +6 more sources

Post-Transcriptional HIV-1 Latency: A Promising Target for Therapy? [PDF]

open access: yesViruses
Human Immunodeficiency Virus type 1 (HIV-1) latency represents a significant hurdle in finding a cure for HIV-1 infections, despite tireless research efforts.
Mie Kobayashi-Ishihara   +1 more
doaj   +3 more sources

Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
info:eu-repo/semantics ...
Alexander O. Pasternak   +4 more
doaj   +7 more sources

[Viral latency of HIV-1] [PDF]

open access: yesVirologie (Montrouge, France), 2019
Human immunodeficiency virus (HIV-1) latency is clinically highlighting via the persistence of a residual viral load in cART-treated patients due to the reactivation of cellular reservoirs.
Van Lint, Carine, Bouchat, Sophie
core   +3 more sources

Molecular basis of HIV-1 latency - part I: physiology of HIV-1 latency [PDF]

open access: yesMedecine sciences : M/S, 2010
peer reviewedThe introduction of the highly active antiretroviral therapy (HAART) in 1996 has greatly extended survival and raised hopes for the eradication of HIV-1.
Olivier Rohr   +25 more
core   +5 more sources

Modulation of IRF7-driven transcription as a strategy to control HIV-1 latency [PDF]

open access: yesFrontiers in Immunology
BackgroundThe persistence of latent HIV-1 reservoirs remains a major barrier to achieving a cure for HIV. While latency-reversing agents (LRAs) have been extensively studied, latency-promoting agents (LPAs) offer a complementary strategy to silence viral
Ifeanyi Jude Ezeonwumelu   +19 more
doaj   +2 more sources

Epitranscriptomic m6A modifications during reactivation of HIV-1 latency in CD4+ T cells [PDF]

open access: yesmBio
Despite effective antiretroviral therapy reducing HIV-1 viral loads to undetectable levels, the presence of latently infected CD4+ T cells poses a major barrier to HIV-1 cure.
Tarun Mishra   +5 more
doaj   +2 more sources

Tannic acid reactivates HIV-1 latency by mediating CBX4 degradation [PDF]

open access: yesJournal of Virology
HIV-1 can integrate viral DNA into host cell chromosomes and establish a long-term stable latent viral reservoir, a major obstacle in curing HIV-1 infection. The reactivation of latent proviruses with latency-reversing agents (LRAs) is a prerequisite for
Cancan Chen   +11 more
doaj   +2 more sources

PCID2 dysregulates transcription and viral RNA processing to promote HIV-1 latency [PDF]

open access: yesiScience
Summary: HIV-1 latency results from tightly regulated molecular processes that act at distinct steps of HIV-1 gene expression. Here, we characterize PCI domain-containing 2 (PCID2) protein, a subunit of the transcription and export complex 2 (TREX2 ...
Raquel Crespo   +14 more
doaj   +2 more sources

Corrigendum: Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
Alexander O. Pasternak   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy